Physician profile
Farid Eghbali
NPI 1386614386
$4,504.71
in general payments reported to CMS, 2019-2025
20 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $170 · 2021: $305 · 2022: $240 · 2023: $1,778 · 2024: $1,359 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,331 · Debt Forgiveness: $18.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,331.05 |
| Debt Forgiveness | $18.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,450.00 | 2023-2024 | Optilight, M22 |
| Alcon Vision LLC | $615.70 | 2020-2025 | Argos, Precision 1, Eysuvis |
| Sun Pharmaceutical Industries INC. | $297.29 | 2019-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $275.35 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $216.14 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $130.77 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.63 | 2021 | |
| Abbvie INC. | $72.91 | 2022-2023 | Lumigan, Vuity, Alphagan P |
| Eyevance Pharmaceuticals LLC | $54.73 | 2019-2020 | |
| Amgen INC. | $50.25 | 2024-2025 | Tepezza |
| Allergan, INC. | $50.24 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $47.60 | 2023-2025 | Miebo, Vyzulta |
| Horizon Therapeutics Plc | $39.63 | 2022 | |
| Coopervision INC. | $27.24 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.22 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $18.18 | 2023 | Panoramic Ophthalmoscope |
| Thea Pharma INC. | $17.57 | 2023 | |
| Abb Con-Cise Optical Group LLC | $16.70 | 2019 | |
| Visioneering Technologies, INC. | $7.99 | 2022 | |
| Travere Therapeutics, INC. | $5.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Eghbali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.